Additional information regarding these factors appears in the section entitled Forward-Looking Statements in the press ...
Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results